Chuisheng Zeng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Chuisheng Zeng has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Feibo Xu
School of Life Health Information Science and Engineering, Chongqing University of Posts and Telecommunications, 400065 Chongqing, China
1 shared publication - Fengying Liu
School of Life Health Information Science and Engineering, Chongqing University of Posts and Telecommunications, 400065 Chongqing, China
1 shared publication - Jianzhong Shu
Department of Encephalopathy, Chongqing Hospital of Traditional Chinese Medicine, 400015 Chongqing, China
1 shared publication - Qianqian Liang
School of Life Health Information Science and Engineering, Chongqing University of Posts and Telecommunications, 400065 Chongqing, China
1 shared publication Xiaohong He
School of Life Health Information Science and Engineering, Chongqing University of Posts and Telecommunications, 400065 Chongqing, China
1 shared publication- Xie Yongfang
Chongqing Key Laboratory of Big Data for Bio Intelligence, Chongqing University of Posts and Telecommunications, Chongqing 400065, China
1 shared publication
Latest Publications
- Open Access
- 18 December 2025
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 30 (12) , 43790
Evaluating the Mechanisms of Action of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Ischemic Stroke
The utilization of cell-free therapies derived from extracellular vesicles (EVs) has garnered mounting interest as a promising approach to address the myriad challenges associated with ischemic stroke. These Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) possess considerable therapeutic potential due to their inherent properties, including low immunogenicity, efficient cargo transportation, and the ability to cross the blood-brain barrier. This review examines the mechanisms underlying mesenchymal stem cell-derived EVs in the treatment of ischemic stroke. Future research should aim to identify optimal strategies for EV-based interventions, including combination therapy and preconditioning strategies.
- 18 December 2025
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 30 (12) , 43790
Open AccessEvaluating the Mechanisms of Action of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Ischemic Stroke
The utilization of cell-free therapies derived from extracellular vesicles (EVs) has garnered mounting interest as a promising approach to address the myriad challenges associated with ischemic stroke. These Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) possess considerable therapeutic potential due to their inherent properties, including low immunogenicity, efficient cargo transportation, and the ability to cross the blood-brain barrier. This review examines the mechanisms underlying mesenchymal stem cell-derived EVs in the treatment of ischemic stroke. Future research should aim to identify optimal strategies for EV-based interventions, including combination therapy and preconditioning strategies.